SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-002611
Filing Date
2024-01-31
Accepted
2024-01-31 07:00:22
Documents
16
Period of Report
2024-01-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20240130_8k.htm   iXBRL 8-K 28258
2 EXHIBIT 99.1 ex_621126.htm EX-99.1 16899
  Complete submission text file 0001437749-24-002611.txt   198527

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240131.xsd EX-101.SCH 3849
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240131_def.xml EX-101.DEF 13380
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240131_lab.xml EX-101.LAB 17544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240131_pre.xml EX-101.PRE 13357
17 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240130_8k_htm.xml XML 4630
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 24580608
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)